- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01254760
Comparison of Two Multifocal Contact Lenses Worn on a Daily Disposable Basis
June 26, 2012 updated by: CIBA VISION
The purpose of this trial is to evaluate and compare the clinical performance of two multifocal contact lenses.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
79
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
41 years to 68 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 41 to 68 (inclusive).
- Spectacle add between +0.75 and +2.75D (inclusive).
- Habitual spectacle prescription ≤ 1.00DC (cyl).
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Eye injury or surgery within twelve weeks of enrollment.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Currently enrolled in a clinical trial.
- Prior refractive surgery.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Investigational multifocal / Commercial multifocal
Investigational multifocal contact lenses worn first, with commercial multifocal contact lenses worn second.
Each product worn bilaterally on a daily wear, daily disposable basis for 5 days.
|
Investigational, soft, multifocal contact lens for daily wear, daily disposable use.
Commercially marketed, soft, multifocal contact lens FDA-approved for daily wear, daily disposable use.
Other Names:
|
Other: Commercial multifocal / Investigational multifocal
Commercial multifocal contact lenses worn first, with investigational multifocal contact lenses worn second.
Each product worn bilaterally on a daily wear, daily disposable basis for 5 days.
|
Investigational, soft, multifocal contact lens for daily wear, daily disposable use.
Commercially marketed, soft, multifocal contact lens FDA-approved for daily wear, daily disposable use.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
End of Day Comfort
Time Frame: 5 days of wear, lenses replaced daily
|
End of day comfort was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear.
End of day comfort was measured on a 10-point scale, with 1 being poor and 10 being excellent.
|
5 days of wear, lenses replaced daily
|
End of Day Dryness
Time Frame: 5 days of wear, lenses replaced daily
|
End of day dryness was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear.
End of day dryness was measured on a 10-point scale, with 1 being very dry and 10 being not dry.
|
5 days of wear, lenses replaced daily
|
Handling at Removal
Time Frame: 5 days of wear, lenses replaced daily
|
Handling at removal was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear.
Handling at removal was measured on a 10-point scale, with 1 being poor/difficult and 10 being excellent/easy.
|
5 days of wear, lenses replaced daily
|
Overall Vision
Time Frame: 5 days of wear, lenses replaced daily
|
Overall vision was interpreted and reported by the participant on a questionnaire as a single, retrospective evaluation of 5 days of wear.
Overall vision was measured on a 10-point scale, with 1 being poor and 10 being excellent.
|
5 days of wear, lenses replaced daily
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall Fit
Time Frame: Day 5, lenses replaced daily
|
Overall lens fit was assessed by the investigator at study visit using a biomicroscope, which magnifies the appearance of the contact lens on the participant's eye.
Lens fit was assessed by eye and graded on a 5-point scale, with 2=unacceptably loose, 1= acceptably loose, 0=optimal, -1=acceptably tight, and -2=unacceptably tight
|
Day 5, lenses replaced daily
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
January 1, 2011
Study Completion (Actual)
January 1, 2011
Study Registration Dates
First Submitted
December 3, 2010
First Submitted That Met QC Criteria
December 3, 2010
First Posted (Estimate)
December 7, 2010
Study Record Updates
Last Update Posted (Estimate)
July 10, 2012
Last Update Submitted That Met QC Criteria
June 26, 2012
Last Verified
January 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P-416-C-001 Sub 04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Allotex, Inc.RecruitingPresbyopiaCzechia, Ireland, Turkey, United Kingdom
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, IncRecruiting
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Optall VisionRecruiting
-
Allotex, Inc.TerminatedPresbyopiaBelgium, Ireland, United Kingdom
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
Clinical Trials on Nelfilcon A multifocal contact lens, investigational
-
Alcon ResearchCompletedRefractive Error | Presbyopia | Myopia | Ametropia
-
CIBA VISIONCompletedAstigmatism | Myopia
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
CIBA VISIONCompleted
-
Johnson & Johnson Vision Care, Inc.Completed